Addus HomeCare Corp (ADUS) - Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025. Addus HomeCare Corporation operates as a multi-state provider of in-home services across three segments: Personal Care (non-medical assistance), Hospice (end-of-life care), and Home Health (skilled medical services). As of March 31, 2025, the company operated 260 offices across 23 states, serving approximately 72,000 discrete individuals during the quarter.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Service Revenues | $337.7 million | $280.7 million |
| Gross Profit | $107.7 million (31.9% margin) | $88.2 million (31.4% margin) |
| Operating Income | $30.5 million (9.0% margin) | $23.6 million (8.4% margin) |
| Net Income | $21.2 million | $15.8 million |
| Diluted EPS | $1.16 | $0.97 |
| Cash from Operations | $18.9 million | $38.7 million |
| Cash and Equivalents | $97.0 million | $76.7 million |
| Long-Term Debt (Net) | $198.7 million | $218.4 million |
| Available Credit Capacity | $421.9 million | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net service revenues increased 20.3% year-over-year. Personal Care revenue grew 24.2% (driven by the Gentiva Acquisition and same-store growth), Hospice grew 10.0% (organic growth), and Home Health grew 6.5%.
- Profitability: Net income increased 34.1% to $21.2 million. Operating margins expanded to 9.0% from 8.4%, aided by higher-margin Hospice growth and the New York Asset Sale.
- Acquisitions & Divestitures:
- Acquisitions: Completed the Great Lakes Acquisition (Michigan) for $2.6 million and the Jacksonville Acquisition (Florida) for $0.8 million in Q1 2025. The Q4 2024 Gentiva Acquisition ($353.6 million) significantly contributed to Q1 2025 revenue.
- Divestiture: Continued receiving proceeds from the New York Asset Sale, recording $3.8 million in deferred payments during the quarter.
- Debt Reduction: Repaid $20.0 million on the revolving credit facility. Outstanding revolver balance decreased to $203.0 million from $223.0 million at year-end 2024.
- Cash Flow: Operating cash flow decreased to $18.9 million from $38.7 million, primarily due to timing of accounts receivable collections and government stimulus fund receipts.
Outlook, Risks, and Management Commentary
- Reimbursement Environment:
- Illinois: Benefited from rate increases effective Jan 1, 2025 ($29.63/hr), though future offsets for minimum wage increases are not guaranteed.
- Medicare: Hospice rates increased 2.9% effective Oct 1, 2024. Home Health rates are estimated to increase 0.5% for calendar year 2025.
- Regulatory & Political Risks: Management highlights uncertainty regarding federal spending, potential Medicaid restructuring, and the impact of the new presidential administration's "Department of Government Efficiency" (DOGE) initiatives on federal agencies and funding distribution.
- 80/20 Rule: CMS finalized a rule requiring 80% of Medicaid payments for personal care to go toward direct care worker compensation by mid-2030. The long-term impact is currently indeterminate.
- Labor Market: Continued tight labor market and inflationary pressures pose risks to caregiver recruitment and retention, potentially impacting service delivery.
- Guidance: The filing does not contain specific numerical forward-looking guidance for the full year 2025.
Investor Verification Checklist
- Illinois Concentration: Verify the stability of the Illinois Department on Aging, which accounted for 18.5% of total net service revenues and 23.8% of net accounts receivable.
- DSO Trends: Monitor Days Sales Outstanding (DSO), which increased to 48 days for the Illinois Department on Aging (up from 40 days at year-end 2024), indicating potential collection delays.
- Debt Covenants: Confirm continued compliance with the Total Net Leverage Ratio covenant (max 3.75:1.00) given the variable interest rate environment (current rate 6.32%).
- ARPA Funding: Track the utilization of the remaining $8.7 million in deferred ARPA funding, which must be spent by March 31, 2025, or risk recoupment.
- Acquisition Integration: Assess the integration progress and margin impact of the Gentiva Acquisition, which drove significant revenue but also increased administrative costs.